An Israeli drugmaker says a therapy it is developing reduced deaths among patients battling serious bouts of COVID-19 by 70 percent, and nearly halved hospitalization length in a small trial. A clinical study for MesenCure, conducted in Israel, involved 50 patients hospitalized in serious condition, and a similar size control group that received the best standard of care … [Read more...]
| CLICK HERE To Receive FREE AIMA News and Updates |
|
Israel Is At War and We Need Your Help! Medical Equipment and Suppies Are Desperately Needed. Email info@aima4u.com To Learn What YOU Can Do.
Upcoming Events
